Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

JPL CBRND ENABLING BIOTECHNOLOGIES DNA VACCINE

JPL CBRND Enabling Biotechnology’s mission is medical solutions during a crisis and against future threats. Our vision is to be the nation’s premier service provider enabling rapid development, manu- facture, and fielding of safe and effective countermeasures for preparedness, prevention, protection, response, and recovery from CBRN threats.

OVERVIEW
JPEO-CBRND is working with Ology Bioservices and Inovio Pharmaceuticals to adapt Inovio DNA technology to rapidly manufacture a DNA vaccine to prevent COVID-19 infections. The new DNA vaccine approach offers vaccine stability and ease of large scale production. This effort aims to rapidly and efficiently deliver a vaccine for use by DoD personnel.

WHY DOES DOD NEED THIS?
• There is currently no vaccine to prevent COVID-19 infection
• To ensure service members can be protected against COVID-19
infection
• To maintain strength of the Joint Force during the COVID-19

WHY IS JPEO-CBRND SUPPORTING THIS?
• •

The DOD Advanced Development and Manufacturing (DOD-ADM) capability will be used to manufacture the vaccine Advantages of using the DOD-ADM
- Priority access for DoD emergency requirements
- Provides scalability and surge capacity for DoD needs
pandemic

WHAT IS THE DOD-ADM?
• Multi-product, multi-suite biomanufacturing facility
• Contractor-owned, contractor-operated (Ology Bioservices)
• cGMP compliant/BSL-3 capable
• Can support up to 4 distinct products at once
• Capacity for full production of FDA-approved products

“ EVEN THOUGH THIS THREAT WAS BROUGHT BY MOTHER NATURE INSTEAD OF AN ENEMY, JPEO-CBRND STILL HAS CAPABILITIES TO BRING TO THE FIGHT ” - DR. JASON ROOS

Government Partners
• Office of the Assistant Secretary of Defense for Health Affairs
• Defense Health Agency

Industry Partners
• Inovio Pharmaceuticals
• Ology Bioservices

Funding: Provided by Defense Health Agency
DR. MATTHEW HEPBURN | JOINT PRODUCT LEAD CBRND ENABLING BIOTECHNOLOGIES | 301-619-4557 | [e-mail]

https://jpeocbrnd.army.mil/docs/default-source/default-document-library/jpm-fact-sheet-dna-vaccine_final.pdf?sfvrsn=6acb2dd7_0